Abstract
The diagnosis of Hodgkin’s disease (HD) is based on the presence of typical Reed-Sternberg (RS) cells in an appropriate cellular environment of “reactive” cells. The origin of the neoplastic cells in HD is still controversial (Hsu et al., 1985; Cabanillas et al., 1988; Hsu et al., 1992; Drexler, 1992). Recent data favour the hypothesis that the RS cells and their mononuclear variants (collectively called H-RS cells) originate from lymphoid cells, although conflicting data have been published about the exact lineage (Cibull et al., 1989; Schmid et al., 1991; Drexler, 1992; Herbst et al., 1993; Koduru et al., 1993). Expression of B or T-cell specific markers on H-RS cells has been described (Oka et al., 1988; Bjarni et al., 1989; Cibull et al., 1989; Schmid et al., 1991). The number of H-RS cells expressing lymphoid differentiation markers may vary considerably among the different histological types. In HD, nodular lymphocyte predominant type the neoplastic cells express B-cell markers (Coles et al., 1988; Kadin et al., 1988), whereas in other subtypes B and/or T-cell markers can be found on H-RS cells in a variable proportion of cases (Oka et al., 1988; Kadin et al., 1988; Bjarni et al., 1989; Cibull et al., 1989).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alfieri C, Birkenbach M, Kieff E (1991) Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181:595
Bai MC, Jiwa NM, Horstman A, Vos W, Kluin PH, van der Valk P, Mullink H, Walboomers JMM, Meijer CJLM (1994) Decreased expression of cellular markers in Epstein-Barr virus positive Hodgkin’s disease. J Pathol 174:49
Bjarni A, Agnarsson MD, Marshall E, Kadin ME (1989) The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin’s disease using fixed frozen tissues. Cancer 63:2083
Brooks L, Yao QY, Rickinson AB, Young LS (1992) Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66:2689
Cabanillas F, Pathak S, Trujillo J, Grant G, Cork A, Hagemeister FB, Velasquez WS, McLaughlin P, Redman J, Katz R, Butler JJ, Freireich EJ (1988) Cytogenetic features of Hodgkin’s disease suggest possible origin from a lymphocyte. Blood 71:1615
Calender A, Cordier M, Billaud M, Lenoir GM (1990) Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus (EBV). Int J Cancer 46:658
Cibull ML, Stein H, Gatter KC, Mason DY (1989) The expression of the CD3 antigen in Hodgkin’s disease. Histopathol 15:597
Coles FB, Cartum RW, Pastuszak WT (1988) Hodgkin’s disease lymphocyte-predominant type: immunoreactivity with B-cell antibodies. Mod Pathol 1:274
Cordierbussat M, Billaud M, Calender A, Lenoir GM (1993) Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context. Int J Cancer 53:153
Deacon EM, Pallesen G, Nieboditek G, Crocker J, Brooks L, Rickinson AB, Young LS (1993) Epstein-Barr virus and Hodgkin’s disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 177:339
De Bruin PC, Jiwa M, Oudejans JJ, van der Valk P, van Heerde P, Sabourin JC, Csanaky G, Gaulard P, Noorduyn AL, Willemze R, Meijer CJLM (1994) Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood 83:1612
Delsol G, Stein H, Pulford KAF, Gatter KC, Erber WN, Zinne K, Mason DY (1984) Human lymphoid cells express epithelial membrane antigen. Lancet 17:1124
Drexler HG (1992) Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. Leuk Lymphoma 8:283
Flemington E, Speck SH (1990) Identification of phorbol ester response elements in the promoter of Esptein-Barr virus putative lytic switch gene BZLF1. J Virol 64:1217
Gamier JL, Cooper NR, Cannon MJ (1993) Low expression of CD20 and CD23 in Epstein-Barr virus induced B cell tumours in SCID/hu mice. Am J Pathol 142:353
Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson AB (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107
Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A (1993) Epstein-Barr virus-coded BHRF1 protein, a viral homologue of bcl-2, protects human B-cells from programmed cell death. Proc Natl Acad Sci USA 90:8479
Herbst H, Stein H, Nieboditek G (1993) Epstein-Barr virus and CD30+ malignant lymphomas. Critical Rev Oncol Hematol 4:191
Hsu, S, Xie S, El-Okda MO, Hsu P (1992) Correlation of c-fos/c-jun expression with histiocytic differentiation in Hodgkin’s Reed-Sternberg cells. Am J Pathol 140:155
Hsu SM, Yang K, Jaffe ES (1985) Phenotypic expression of Hodgkin’s and Reed-Sternberg cells in Hodgkin’s disease. Am J Pathol 118:209
Hsu S, Jaffe ES (1984) Leu Ml and peanut agglutinin stain the neoplastic cells of Hodgkin’s disease. Am J Clin Pathol 82:29
Hsu DW, de Waal Malefyt R, Fiorentino DF, Dang MN, Vieira P, de Vries J, Spits H, Mosmann TR, Moore KW (1990) Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250:830
Hummel M, Anagnostopoulos I, Dallenbach F, Korbjuhn P, Dimmler C, Stein H (1992) EBV infection patterns in Hodgkin’s disease and normal lymphoid tissue: expression and cellular localisation of EBV gene products. Br J Haematol 82:689
Jiwa NM, van der Valk P, Mullink H, Vos W, Horstman A, Maurice MM, Olde-Weghuis DEM, Walboomers JMM, Meijer CJLM (1992) Epstein-Barr virus DNA in Reed-Sternberg cell of Hodgkin’s disease is frequently associated with CR2 (EBV receptor) expression. Histopathol 21:51
Jiwa NM, Kanavaros P, de Bruin PC, van der Valk P, Horstman A, Vos W, Mullink H, Walboomers JMM, Meijer CJLM (1993) Presence of Epstein-Barr virus harbouring small and intermediate-sized cells in Hodgkin’s disease. Is there a relationship with Reed-Sternberg cells? J Pathol 170:129
Jiwa NM, Kanavaros P, van der Valk P, Walboomers JMM, Horstman A, Vos W, Mullink H, Meijer CJLM (1993) Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus. J Clin Pathol 46:211
Jiwa NM, Oudejans JJ, Bai MC, van den Brule AJC, Horstman A, Vos W, van der Walk P, Kluin PhM, Walboomers JMM, Meijer CJLM (1995) Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin’s disease: implications for different pathogenic mechanisms. Histopathol 26:547
Kadin ME, Muramoto L, Said J (1988) Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin’s disease. Am J Pathol 130:345
Kanavaros P, Jiwa NM, van der Val PK, Walboomers JMM, Horstman A, Meijer CJLM (1993) Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin’s disease and non-Hodgkin’s lymphomas arising in patients without overt pre-existing immunodeficiency. Hum Pathol 24:725
Kelly K, Cochran BH, Stiles CD, Leder P (1983) Cell specific regulation of the c-myc gene by lymphocyte mitogen and platelet-derived growth factor. Cell 35:603
Koduru PRK, Susin M, Schulman P, Catell D, Goh JC, Krap L, Broome JD (1993) Phenotypic and genotypic characterisation of Hodgkin’s disease. Am J Hematol 44:117
Lear AL, Rowe MG, Kurilla S, Lee S, Henderson S, Kieff E, Rickinson AB (1992) The Epstein-Barr virus (EBV) nuclear antigen-1 BamHl F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J Virol 66:7461
Mannick JB, Cohen JL, Birkenbach M, Marchini A, Kieff E (1991) The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J Virol 65:6826
Martin JM, Veis D, Korsmeyer SJ, Sugden B (1993) Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of bcl-2. J Virol 67:5269
Miller CL, Longnecker R, Kieff E (1993) Epstein-Barr virus latent membrane protein 2A blocks calcium mobilisation in B lymphocytes. J Virol 67:3087
Miyazaki I, Cheung RK, Dosch HM (1993) Viral interleukin-10 is critical for the induction of B-cell growth transformation by Epstein-Barr virus. J Exp Med 178:439
Niedobitek G, Fahraeus R, Herbst H, Latza U, Ferszt A, Klein G (1992) The Epstein-Barr virus encoded membrane protein (LMP) induces phenotypic changes in epithelial cells. Virchows Archiv (B cell Pathol) 62:55
O’Grady J, Stewart S, Lowrey J, Howie SEM, Krajewski AS (1994) CD40 expression in Hodgkin’s disease. Am J Pathol 144:21
Oka K, Mori N, Kojima M (1988) Anti-leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin’s disease. Arch Pathol Lab Med 112:139
Pallesen G, Hamilton Dutoit SJ, Rowe M, Young LS (1991) Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin’s disease. Lancet 337:320
Pallesen G, Sandvej K, Hamilton Dutoit SJ, Rowe M, Young LS (1991) Activation of Epstein-Barr virus replication in Hodgkin and Reed-Sternberg cells. Blood 78:1162
Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt’s lymphoma cells. EMBO J 6:2743
Schmid C, Pan L, Diss T, Isaacson PG (1991) Expression of B-cell antigens by Hodgkin’s and Reed-Sternberg cells. Am J Pathol 139:701
Speck SH, Strominger JL (1989) Transcription of Epstein-Barr virus in latently infected, growth transformed lymphocytes. Adv Vir Onc 8:133
Stewart JP, Rooney CM (1992) The interleukin-10 homolog encoded by Epstein-Barr virus enhances the reactivation of virus specific cytotoxic T-cell and HLA unrestricted killer cell responses. Virology 191:773
Sugden, B (1992) EBV’s open sesame. TIBS 17:239
Szekely L, Selivanova G, Magnusson KP, Klein G, Wiman KG (1993) EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci USA 90:5455
Vaux DL, Cory S, Adams JM (1988) bcl-2 gene promotes haemopoietic cell survival and co-operates with c-myc to immortalise pre-B cells. Nature 335:440
Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E (1990) Epstein-Barr virus latent membrane protein (LMP-1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP-1 co-operatively induce CD23. J Virol 64:2309
Weiss LM, Chen YY, Liu XF, Shibata D (1991) Epstein-Barr virus and Hodgkin’s disease: a correlative in situ hybridisation and polymerase chain reaction study. Am J Pathol 139:1259
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Plenum Press, New York
About this chapter
Cite this chapter
Jiwa, M.N., Oudejans, J.J., van den Brule, A.J., van der Valk, P., Walboomers, J.M., Meijer, C.J.L.M. (1995). Relationship Between Expression of Cellular Genes and Epstein-Barr Virus in Hodgkin’s Disease. In: Jarrett, R.F. (eds) Etiology of Hodgkin’s Disease. NATO ASI Series, vol 280. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0339-8_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0339-8_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8005-4
Online ISBN: 978-1-4613-0339-8
eBook Packages: Springer Book Archive